NU SKIN ENTERPRISES, INC.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
NUS$4.03-5.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Cash Flows (Unaudited)
| Three Months Ended | ||
|---|---|---|
| March 31, | ||
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income | $1,836 | $107,515 |
| Adjustments to reconcile net income to cash flows from operating activities: | ||
| Gain on sale of business | - | (176,162) |
| Impairment of goodwill, fixed assets and other intangibles | 1,839 | 25,114 |
| Unrealized losses on equity investments | - | 28,077 |
| Depreciation and amortization | 12,342 | 14,206 |
| Non-cash lease expense | 6,451 | 6,438 |
| Stock-based compensation | 3,695 | 9,308 |
| Inventory write-down | 4,750 | 3,085 |
| Foreign currency losses (gains) | (1,387) | 931 |
| Loss on disposal of assets | 303 | 58 |
| Deferred taxes | 1,723 | 631 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (5,737) | (5,878) |
| Inventories, net | (5,882) | (32) |
| Prepaid expenses and other | (9,138) | 9,612 |
| Other assets | 199 | 1,796 |
| Accounts payable | 2,750 | (1,439) |
| Accrued expenses | (14,696) | (21,016) |
| Other liabilities | (2,967) | (1,855) |
| Net cash (used in) provided by operating activities | (3,919) | 389 |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (13,714) | (13,584) |
| Purchases of investments | (573) | - |
| Proceeds on investment sales | - | 1,403 |
| Proceeds from sale of business, net | - | 193,725 |
| Net cash (used in) provided by investing activities | (14,287) | 181,544 |
| Cash flows from financing activities: | ||
| Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards | (4,157) | (1,162) |
| Payment of cash dividends | (2,873) | (3,002) |
| Repurchases of shares of common stock | (5,011) | (5,012) |
| Finance lease principal payments | (489) | (621) |
| Proceeds from debt | 225,000 | - |
| Payments of debt | (225,000) | (155,000) |
| Payment of debt issuance costs | (1,369) | - |
| Purchase of noncontrolling interest | (6,500) | (1,498) |
| Net cash used in financing activities | (20,399) | (166,295) |
| Effect of exchange rate changes on cash | (1,371) | 1,249 |
| Net (decrease) increase in cash and cash equivalents | (39,976) | 16,887 |
| Cash and cash equivalents, beginning of period | 238,630 | 186,883 |
| Cash and cash equivalents, end of period | $198,654 | $203,770 |
Notes
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.